• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    34 Stocks Moving In Monday's Mid-Day Session

    4/25/22 12:00:36 PM ET
    $AMTI
    $ARDX
    $AXSM
    $BBAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMTI alert in real time by email

    Gainers

    • Nkarta, Inc. (NASDAQ:NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen receptor natural killer cell therapy candidates, NKX101 and NKX019.
    • ERYTECH Pharma S.A. (NASDAQ:ERYP) shares climbed 45.9% to $1.78. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial as treatment for hypersensitive ALL in the British Journal of Haematology.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) gained 30.6% to $4.35 after the company reported it filed a provisional patent application in the US covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) jumped 29.4% to $3.69.
    • Ardelyx, Inc. (NASDAQ:ARDX) rose 26.5% to $0.9471 after the company reported it received an interim response from the OND, CDER and FDA for the company's second level of appeal of the Complete Response Letter for XPHOZAH.
    • Cango Inc. (NYSE:CANG) shares gained 17.4% to $2.77. Cango, last month, reported worse-than-expected Q4 EPS and sales results.
    • Dogness (International) Corporation (NASDAQ:DOGZ) jumped 16.5% to $4.09.
    • BioLife Solutions, Inc. (NASDAQ:BLFS) gained 14% to $14.35. Oppenheimer upgraded BioLife Solns from Perform to Outperform and announced a $28 price target.
    • INmune Bio, Inc. (NASDAQ:INMB) jumped 13.7% to $7.80.
    • Sky Harbour Group Corporation (NASDAQ:SKYH) gained 13.6% to $9.10.
    • Cenntro Electric Group Limited (NASDAQ:CENN) rose 13.6% to $1.9316 after gaining around 7% on Friday.
    • Eros STX Global Corporation (NYSE:ESGC) gained 12.5% to $2.52.
    • PS Business Parks, Inc. (NYSE:PSB) jumped 12.1% to $187.93 after the company announced it will be acquired by affiliates of Blackstone Real Estate for $7.6 billion.
    • Silicon Motion Technology Corporation (NASDAQ:SIMO) rose 9.9% to $84.68 after Bloomberg reported that the company exploring a potential sale amid takeover interest.
    • BigBear.ai Holdings, Inc. (NASDAQ:BBAI) gained 8.5% to $9.28.
    • Joby Aviation, Inc. (NYSE:JOBY) jumped 8.3% to $5.38.
    • Graphite Bio, Inc. (NASDAQ:GRPH) gained 8% to $4.32.


    Losers

    • Eliem Therapeutics, Inc. (NASDAQ:ELYM) shares dipped 57% to $2.80 after the company announced the Phase 2a clinical trial of ETX-810 in diabetic peripheral neuropathic pain did not achieve the primary endpoint. The company also announced it elected to delay enrollment of its Phase 2a clinical trials of ETX-155 in major depressive disorder and perimenopausal depression.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares fell 53.6% to $0.8351. Clarus Therapeutics reported pricing of upsized underwritten public offering at $1.10 per share.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 42.1% to $15.30. ToughBuilt Industries reported a 1-for-150 reverse stock split as part of Nasdaq compliance plan.
    • Axsome Therapeutics, Inc. (NASDAQ:AXSM) fell 20.5% to $31.08 after the company reported it was informed by the FDA that chemistry, manufacturing, and control issues identified during the FDA's review of its NDA for its AXS-07 product candidate are unresolved.
    • EuroDry Ltd. (NASDAQ:EDRY) dipped 17.9% to $32.67. EuroDry recently announced plans to acquire M/V Santa Cruz Bulker for $15.75 million.
    • Cypress Environmental Partners, L.P. (NYSE:CELP) fell 17.5% to $0.5296 after the company said an affiliate of Argonaut Private Equity has acquired 100% of Cypress’s senior secured debt from the seven existing lenders.
    • Cyngn Inc. (NASDAQ:CYN) fell 17.5% to $2.2108 after climbing around 27% on Friday. Cyngn recently announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.
    • HighPeak Energy, Inc. (NASDAQ:HPK) dropped 16.5% to $31.49.
    • Navios Maritime Holdings Inc. (NYSE:NM) dropped 16% to $3.70.
    • FingerMotion, Inc. (NASDAQ:FNGR) declined 14.1% to $2.26.
    • Applied Molecular Transport Inc. (NASDAQ:AMTI) dipped 13% to $4.07 as the company reported top-line Phase 2 results from FILLMORE trial of oral AMT-101 in patients with chronic pouchitis.
    • Golden Ocean Group Limited (NASDAQ:GOGL) fell 12.6% to $11.44.
    • Koninklijke Philips N.V. (NYSE:PHG) shares fell 11.7% to $26.74. Philips reported a first-quarter FY22 sales growth of 2.6% year-on-year to €3.9 billion.
    • Moving iMage Technologies, Inc. (NASDAQ:MITQ) fell 10% to $1.4313. Moving iMage Technologies shares climbed 38% on Friday after the company and SNDBX announced a strategic partnership to bring the full theatre experience to the gaming and e-Sports market.
    • TradeUP Global Corporation (NASDAQ:TUGC) dipped 10% to $8.96.
    • RPC, Inc. (NYSE:RES) fell 9.7% to $9.92.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 9.6% to $2.0529. Vallon Pharmaceuticals shares jumped more than 100% on Friday after the company announced a review of strategic alternatives.
    Get the next $AMTI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTI
    $ARDX
    $AXSM
    $BBAI

    CompanyDatePrice TargetRatingAnalyst
    Silicon Motion Technology Corporation
    $SIMO
    1/22/2026Outperform
    William Blair
    Ardelyx Inc.
    $ARDX
    1/9/2026Neutral → Overweight
    Piper Sandler
    Axsome Therapeutics Inc.
    $AXSM
    1/8/2026$204.00Overweight → Equal-Weight
    Morgan Stanley
    BigBear.ai Inc.
    $BBAI
    1/7/2026$6.00Overweight → Neutral
    Cantor Fitzgerald
    Koninklijke Philips N.V. NY Registry Shares
    $PHG
    12/17/2025Sector Perform
    RBC Capital Mkts
    Joby Aviation Inc.
    $JOBY
    12/1/2025$10.00Sell
    Goldman
    Sky Harbour Group Corporation
    $SKYH
    10/27/2025$13.00Buy
    BTIG Research
    HighPeak Energy Inc.
    $HPK
    10/14/2025$12.00Buy
    Roth Capital
    More analyst ratings

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Thompson Michael N. Jr. bought $14,564 worth of shares (1,100 units at $13.24) (SEC Form 4)

    4 - Joby Aviation, Inc. (0001819848) (Issuer)

    1/2/26 4:43:46 PM ET
    $JOBY
    Aerospace
    Industrials

    Director Leong Yew Poh decreased direct ownership by 6% to 160,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/29/25 6:26:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    Director Leong Yew Poh decreased direct ownership by 6% to 170,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/8/25 7:08:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Mcaleenan Kevin covered exercise/tax liability with 48,691 shares, decreasing direct ownership by 4% to 1,165,294 units (SEC Form 4)

    4 - BigBear.ai Holdings, Inc. (0001836981) (Issuer)

    2/4/26 6:48:48 AM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Officer Dehoff Kate converted options into 22,547 shares and sold $85,873 worth of shares (8,194 units at $10.48), increasing direct ownership by 10% to 163,722 units (SEC Form 4)

    4 - Joby Aviation, Inc. (0001819848) (Issuer)

    2/3/26 5:20:45 PM ET
    $JOBY
    Aerospace
    Industrials

    Chief Executive Officer Tabuteau Herriot exercised 32,410 shares at a strike of $8.02 and sold $6,015,296 worth of shares (32,410 units at $185.60) (SEC Form 4)

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    2/2/26 6:30:04 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cango Inc. Releases 2025 Letter to Shareholders

    DALLAS, Feb. 9, 2026 /PRNewswire/ -- Cango Inc. (NYSE:CANG) today released a letter to shareholders highlighting its strategic transformation and roadmap to evolve from a global Bitcoin miner into an AI compute infrastructure platform. Throughout the past year, Cango executed a disciplined entry into the industry, balancing speed with operational prudence to build its position as a leading Bitcoin miner with a global footprint across four key regions. Key commitments were delivered, including acquiring and enhancing hashrate efficiency of 50 EH/s of on-rack machines, adopting

    2/9/26 7:32:00 AM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    Cango Inc. Releases 2025 Letter to Shareholders

    DALLAS, Feb. 9, 2026 /PRNewswire/ -- Dear Shareholders, The year 2025 marked a pivotal chapter in our strategic transformation, representing a new phase of entrepreneurship for Cango. As we enter 2026, we believe it is appropriate to reflect on our progress and sharpen our focus for the opportunities ahead.  Over the past year, we have executed a disciplined entry into the industry, balancing speed with operational prudence to steadily build our position as a leading Bitcoin miner with a global footprint across four key regions.Importantly, we have delivered on several key com

    2/9/26 7:04:00 AM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    Cango Inc. Completes Bitcoin Sale to Strengthen Financial Position and Advance AI Transformation

    DALLAS, Feb. 9, 2026 /PRNewswire/ -- Cango Inc. (NYSE:CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced that, based on a comprehensive assessment of current market conditions and upon approval of the Company's Board of Directors, it completed the sale of 4,451 Bitcoin on the open market during the past weekend, which were settled directly in USDT for aggregate net proceeds of approximately US$305 million in equivalent value. The full amount of the USDT proceeds has been utilized to partially repay a Bitcoin-collateralized loan.

    2/9/26 6:26:00 AM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    SEC Filings

    View All

    Moving iMage Technologies Inc. filed SEC Form 8-K: Shareholder Director Nominations

    8-K - MOVING iMAGE TECHNOLOGIES INC. (0001770236) (Filer)

    2/6/26 12:36:28 PM ET
    $MITQ
    Industrial Machinery/Components
    Consumer Discretionary

    Sunshine Biopharma Inc. filed SEC Form 8-K: Leadership Update

    8-K - Sunshine Biopharma Inc. (0001402328) (Filer)

    2/5/26 4:16:20 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RPC Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - RPC INC (0000742278) (Filer)

    2/3/26 6:45:30 AM ET
    $RES
    Oilfield Services/Equipment
    Energy

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Silicon Motion

    William Blair initiated coverage of Silicon Motion with a rating of Outperform

    1/22/26 8:30:26 AM ET
    $SIMO
    Semiconductors
    Technology

    Ardelyx upgraded by Piper Sandler

    Piper Sandler upgraded Ardelyx from Neutral to Overweight

    1/9/26 8:23:44 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Axsome Therapeutics downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Axsome Therapeutics from Overweight to Equal-Weight and set a new price target of $204.00

    1/8/26 8:36:26 AM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    Leadership Updates

    Live Leadership Updates

    View All

    Cango Inc. Completes Bitcoin Sale to Strengthen Financial Position and Advance AI Transformation

    DALLAS, Feb. 9, 2026 /PRNewswire/ -- Cango Inc. (NYSE:CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced that, based on a comprehensive assessment of current market conditions and upon approval of the Company's Board of Directors, it completed the sale of 4,451 Bitcoin on the open market during the past weekend, which were settled directly in USDT for aggregate net proceeds of approximately US$305 million in equivalent value. The full amount of the USDT proceeds has been utilized to partially repay a Bitcoin-collateralized loan.

    2/9/26 6:26:00 AM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    Cyngn Partners with Chandler Automation, Expands into Agriculture

    MOUNTAIN VIEW, Calif., Dec. 23, 2025 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced that Chandler Automation has joined its dealer network and will begin offering Cyngn's autonomous DriveMod Tugger to food processors and packers in the agriculture sector. Chandler Automation is a full-service partner in factory automation, specializing in optical sorting, inspection, robotic palletizing, and custom processing machinery. Known for delivering tailored, high-performance systems, Chandler empowers food processors to reduce labor costs, boost efficiency, and stay competitive wi

    12/23/25 7:00:00 AM ET
    $CYN
    EDP Services
    Technology

    Mission Critical Group Appoints Julie Peffer as Chief Financial Officer

    MCKINNEY, Texas, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Mission Critical Group ("MCG"), a critical power infrastructure company specializing in the design, manufacturing, delivery, and service of advanced electrical systems, today announces the appointment of Julie Peffer as Chief Financial Officer. Peffer brings more than three decades of experience leading financial operations and strategic growth initiatives across global organizations, including Amazon Web Services (AWS), Flowserve, Raytheon, Lennox International, and Textron. She joins MCG from BigBear.ai (NYSE:BBAI), where she served as CFO and guided the company's financial strategy through rapid expansion in the defense and artificial

    10/21/25 8:05:00 AM ET
    $BBAI
    $NINE
    Computer Software: Prepackaged Software
    Technology
    Oilfield Services/Equipment
    Energy

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    Financials

    Live finance-specific insights

    View All

    Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026

    WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, February 19, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the full year and fourth quarter of 2025. The call will include commentary from members of the Ardelyx Executive Leadership Team including Mike Raab, President and Chief Executive Officer, Sue Hohenleitner, Chief Financial Officer, Eric Foster, Chief Commercial Officer, and Laura

    2/5/26 8:00:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Silicon Motion Announces Results for the Fourth Quarter and Year Ended December 31, 2025

    Business Highlights Fourth quarter of 2025 sales increased 15% Q/Q and increased 46% Y/Y SSD controller sales: 4Q of 2025 increased 25% to 30% Q/Q and increased 35% to 40% Y/YeMMC+UFS controller sales: 4Q of 2025 increased 0% to 5% Q/Q and increased 50% to 55% Y/YSSD solutions sales: 4Q of 2025 increased 125% to 130% Q/Q and increased 110% to 115% Y/Y Announced annual cash dividend of $2.00 per American Depositary Share ("ADS") Financial Highlights  4Q 2025 GAAP4Q 2025 Non-GAAP*•   Net sales$278.5 million (+15% Q/Q, +46% Y/Y)$278.5 million (+15% Q/Q, +46% Y/Y)•   Gross margin49.1%49.2%•   Operating margin11.4%19.3%•   Earnings per diluted ADS$1.41$1.26  Full Year 2025 GAAPFull Year 2025 N

    2/3/26 6:00:00 PM ET
    $SIMO
    Semiconductors
    Technology

    RPC, Inc. Reports Fourth Quarter And Full Year 2025 Financial Results

    ATLANTA, Feb. 3, 2026 /PRNewswire/ -- RPC, Inc. (NYSE:RES) ("RPC" or the "Company"), a leading diversified oilfield services company, announced its unaudited results for the fourth quarter and full year ended December 31, 2025. Non-GAAP and adjusted measures may include adjusted revenues, adjusted operating income, adjusted net income, adjusted net income margin, adjusted earnings per share (diluted), EBITDA and adjusted EBITDA, adjusted EBITDA margin, and free cash flow which are reconciled to the most directly comparable GAAP measures in the appendices of this earnings release. Sequential comparisons are to 3Q:25. The Company believes quarterly sequential comparisons are most useful in as

    2/3/26 6:45:00 AM ET
    $RES
    Oilfield Services/Equipment
    Energy

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    $AMTI
    $ARDX
    $AXSM
    $BBAI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care